(Total Views: 280)
Posted On: 07/11/2018 2:01:11 PM
Post# of 30015
![Avatar](https://investorshangout.com/images/ProfileImages/no_avatar_available.jpg)
I see both of these answers as very interesting.
Almost foreshadowing....
WuXi: How would you describe the progress being made in finding new approaches for developing drugs to treat neurological disorders, including Parkinson’s disease?
Gerald Commissiong: I think emerging concepts that have given rise to new cancer therapies are changing the way scientists look at biology in general. What’s becoming clear is that the one compound, one target approach has reached some of its limits in terms of how it can positively impact complex medical conditions and new paradigms are being thought of in terms of systems approaches. With that in mind, complementary approaches to biology are being combined into advanced therapy development for several neurological disorders, including Parkinson’s disease.
WuXi: What scientific breakthroughs are needed to better understand the causes and progression of Parkinson’s?
Gerald Commissiong: Reliable biomarkers that allow us to study pre-symptomatic patients are critical to expanding our understanding in this field because we will be able to start trying experimental treatments on patients that have enough neurons left to make a significant regenerative impact.
Aloha
Almost foreshadowing....
WuXi: How would you describe the progress being made in finding new approaches for developing drugs to treat neurological disorders, including Parkinson’s disease?
Gerald Commissiong: I think emerging concepts that have given rise to new cancer therapies are changing the way scientists look at biology in general. What’s becoming clear is that the one compound, one target approach has reached some of its limits in terms of how it can positively impact complex medical conditions and new paradigms are being thought of in terms of systems approaches. With that in mind, complementary approaches to biology are being combined into advanced therapy development for several neurological disorders, including Parkinson’s disease.
WuXi: What scientific breakthroughs are needed to better understand the causes and progression of Parkinson’s?
Gerald Commissiong: Reliable biomarkers that allow us to study pre-symptomatic patients are critical to expanding our understanding in this field because we will be able to start trying experimental treatments on patients that have enough neurons left to make a significant regenerative impact.
Aloha
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)